Response to “Vagus nerve stimulation: Urgent need for the critical reappraisal of clinical effectiveness”
نویسندگان
چکیده
منابع مشابه
Response to “Vagus nerve stimulation: Urgent need for the critical reappraisal of clinical effectiveness”
Response to ''Vagus nerve stimulation: Urgent need for the critical reappraisal of clinical effectiveness'' We have read with interest a recent editorial written by Dr. Hoppe 1 about our article ''Long-term results of vagal nerve stimulation for adults with medication-resistant epilepsy who have been on unchanged antiepileptic medication'', 2 and we are surprised about his comments and conclusi...
متن کاملVagus nerve stimulation: Urgent need for the critical reappraisal of clinical effectiveness
Vagus nerve stimulation (VNS) received approval for medical use by the European authorities in 1994 and by the US Food and Drug Administration in 1997. Today, about fifteen years later, VNS may fairly be regarded as the third pillar of epilepsy treatment, besides antiepileptic drugs (AEDs) and epilepsy surgery. More than 60,000 stimulators had been implanted for the treatment of epilepsy by Nov...
متن کاملClinical Policy Title: Vagus nerve stimulation (VNS)
ABOUT THIS POLICY: AmeriHealth Caritas Louisiana has developed clinical policies to assist with making coverage determinations. AmeriHealth Caritas Louisiana’s clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid Services (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional so...
متن کاملClinical Policy Bulletin: Vagus Nerve Stimulation
Aetna considers vagus nerve electrical stimulators medically necessary durable medical equipment (DME) for shortening the duration or reducing the severity of seizures in members with partial onset seizures who remain refractory to optimal anti-epileptic medications and/or surgical intervention, or who have debilitating side effects from anti-epileptic medications. (Note: Electronic analysis of...
متن کاملDurability of antidepressant response to vagus nerve stimulation (VNS).
This study characterized the durability of improvement in patients who responded early or late while receiving vagus nerve stimulation (VNS). In both a pilot and pivotal study, patients were identified who had at least a 50% reduction in symptom scores 3 months (early responders) or 12 months (late responders) after starting VNS. Probabilities were determined for maintenance of response at 12-m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Seizure
سال: 2013
ISSN: 1059-1311
DOI: 10.1016/j.seizure.2013.03.009